No items found.

Fairlight
Insights Series - Sydney

Q4 earnings challenge yesterdays SMID myths

Perennial Partners Offices - Level 27, 88 Phillip Street, Sydney
Tuesday 12 March, 2024
12:15pm to 1.45pm


Over the past five years, the Fairlight team has focused on capturing alpha in the small and mid cap (SMID) market and navigating around a number of the commonly held beliefs regarding active investing in the sector.

Please join us for lunch where we will provide an update regarding the operating results reported by portfolio holdings in the recently completed Q4 reporting season, including:

• At a macro level, what are the key themes and drivers behind Q4 reported results?

• At a micro level, which companies are surprising on earnings?

• What guidance is being provided around outlook for earnings?

In addition, the team will use these and other specific business examples to debunk several common myths around SMID investing, including:

• Myth 1 - Large cap companies have superior pricing power during inflationary periods

• Myth 2 - Large cap companies are inherently ‘safer’ than SMID companies

• Myth 3 - Large cap companies are ‘higher quality’ than those in the SMID market


We hope you can take this opportunity to join us, please reserve your seat via the link below:

2023 outlook for quality investors

Perennial Partners Offices - 55 Collins Street, Melbourne
Thursday 9 March,
12:15pm to 1.45pm


As with prior periods including 1973-1975 and 1981-1983, the last year has seen strong headwinds for investors with a quality style.

Against this backdrop, Fairlight Senior Portfolio Manager Nick Cregan explores the
consistency of the quality style through time and provides observations on pockets of the market where quality is currently available at compelling valuations.


Please join us for a lunch to address the following key questions:

  • What are the long-term benefits of investing with a quality framework?
  • Are these benefits equally distributed between investors in small cap and large cap companies?
  • Under which market conditions do quality investors typically face most headwinds?
  • During these periods, which pockets within the global small and mid cap market show most attractive prospective returns?
  • What are the typical catalysts for these quality companies to outperform?

We hope you will take the opportunity to join us.

Please reserve your seat with the link below as capacity is limited

Q4 earnings challenge yesterdays SMID myths

Dexus Place - Level 31, 1 Eagle Street, Brisbane
Tuesday 5 March, 2024
12:15pm to 1.45pm


Over the past five years, the Fairlight team has focused on capturing alpha in the small and mid cap (SMID) market and navigating around a number of the commonly held beliefs regarding active investing in the sector.

Please join us for lunch where we will provide an update regarding the operating results reported by portfolio holdings in the recently completed Q4 reporting season, including:

• At a macro level, what are the key themes and drivers behind Q4 reported results?

• At a micro level, which companies are surprising on earnings?

• What guidance is being provided around outlook for earnings?

In addition, the team will use these and other specific business examples to debunk several common myths around SMID investing, including:

• Myth 1 - Large cap companies have superior pricing power during inflationary periods

• Myth 2 - Large cap companies are inherently ‘safer’ than SMID companies

• Myth 3 - Large cap companies are ‘higher quality’ than those in the SMID market


We hope you can take this opportunity to join us, please reserve your seat via the link below:

Q4 earnings challenge yesterdays SMID myths

Dexus Place - Level 6, 80 Collins Street, Melbourne
Thursday 7 March, 2024
12:15pm to 1.45pm


Over the past five years, the Fairlight team has focused on capturing alpha in the small and mid cap (SMID) market and navigating around a number of the commonly held beliefs regarding active investing in the sector.

Please join us for lunch where we will provide an update regarding the operating results reported by portfolio holdings in the recently completed Q4 reporting season, including:

• At a macro level, what are the key themes and drivers behind Q4 reported results?

• At a micro level, which companies are surprising on earnings?

• What guidance is being provided around outlook for earnings?

In addition, the team will use these and other specific business examples to debunk several common myths around SMID investing, including:

• Myth 1 - Large cap companies have superior pricing power during inflationary periods

• Myth 2 - Large cap companies are inherently ‘safer’ than SMID companies

• Myth 3 - Large cap companies are ‘higher quality’ than those in the SMID market


We hope you can take this opportunity to join us, please reserve your seat via the link below: